Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09RNP
|
||||
| Former ID |
DCL000667
|
||||
| Drug Name |
GSK 679769
|
||||
| Indication | Incontinence; Anxiety disorder; Chemotherapyinduced emesis; Major depressive disorder [ICD9: 296.2, 296.3, 300, 787, 787.6, 788.3; ICD10:F32, F33, F40-F42, N39.3-N39.4] | Discontinued in Phase 2 | [536188] | ||
| Company |
GlaxoSmithKline
|
||||
| Target and Pathway | |||||
| Target(s) | Substance-P receptor | Target Info | Antagonist | [536188] | |
| PANTHER Pathway | CCKR signaling map ST | ||||
| Reactome | G alpha (q) signalling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.